Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2021

May 19, 2021

31971_dirs_2021-05-18_15e3a568-2f6a-4e7b-bae8-556604241660.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-05-14

Reporting Person: Hartman Curt R (Director, President, CEO and Chair)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-14 Common Stock S 8030 $142.85 Disposed 114827 Direct
2021-05-14 Common Stock S 5000 $142.89 Disposed 109827 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.86 to $142.97. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.